4.7 Article

Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort

Journal

CLINICAL INFECTIOUS DISEASES
Volume 61, Issue 12, Pages 1781-1788

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/civ749

Keywords

Clostridium difficile; complications; mortality; risk factors; ribotype 027

Funding

  1. Canadian Institutes of Health Research [MOP-74514]
  2. Fonds de recherche du Quebec-Sante

Ask authors/readers for more resources

Background. Clostridium difficile infection (CDI) is the most common cause of nosocomial infectious diarrhea and may result in severe complications including death. We conducted a prospective study to identify risk factors for complications of CDI (cCDI). Methods. Adult inpatients with confirmed CDI in 10 Canadian hospitals were enrolled and followed for 90 days. Potential risk factors were measured within 24 hours of diagnosis. Isolates were typed by polymerase chain reaction ribotyping. cCDI was defined as 1 or more of the following: colonic perforation, toxic megacolon, colectomy, admission to an intensive care unit for cCDI, or if CDI contributed to death within 30 days of enrollment. Risk factors for cCDI were investigated by logistic regression. Results. A total of 1380 patients were enrolled. cCDI was observed in 8% of patients. The ribotype was identified in 922 patients, of whom 52% were infected with R027. Age >= 80 years, heart rate > 90/minute, respiratory rate > 20/minute, white cell count < 4 x 10(9)/L or >= 20 x 10(9)/L, albumin < 25 g/L, blood urea nitrogen > 7 mmol/L, and C-reactive protein >= 150 mg/L were independently associated with cCDI. A higher frequency of cCDI was observed among R027-infected patients (10.9% vs 7.2%), but the association was not significant in adjusted analysis. Conclusions. CDI complications were associated with older age, abnormal blood tests, and abnormal vital signs. These factors, which are readily available to clinicians at the time of diagnosis, could be used for outcome prediction and risk stratification to select patients who may need closer monitoring or more aggressive therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available